Literature DB >> 12153984

Analysis of paradoxical observations on the association between leptin and insulin resistance.

Rolando B Ceddia1, Heikki A Koistinen, Juleen R Zierath, Gary Sweeney.   

Abstract

Obesity is commonly associated with the development of insulin resistance and diabetes in humans and rodents. Insulin resistance and diabetes are observed in lipoatrophic individuals or rodent models of lipoatrophy. Here we focus on the role of leptin, the product of the obesity (ob) gene, in the development of insulin resistance and diabetes associated with obesity and lipoatrophy. We review the reported effects of leptin on whole body glucose metabolism and compare and contrast these with direct effects on skeletal muscle, fat and liver. This summary of paradoxical observations on the effects of leptin on glucose homeostasis and the ability of leptin to induce or improve insulin resistance suggests that a complex interplay exists between direct peripheral and centrally mediated effects of the hormone. Evidence suggesting that leptin acts as a mediator of insulin release from pancreatic beta cells is reviewed. Finally, intracellular signaling mechanisms stimulated by both leptin and insulin are discussed, with potential points of cross-talk suggested.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12153984     DOI: 10.1096/fj.02-0158rev

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  55 in total

1.  Sleep Apnea and Metabolic Dysfunction: Cause or Co-Relation?

Authors:  R Nisha Aurora; Naresh M Punjabi
Journal:  Sleep Med Clin       Date:  2007-06-01

2.  Diet-induced obesity is associated with hyperleptinemia, hyperinsulinemia, hepatic steatosis, and glomerulopathy in C57Bl/6J mice.

Authors:  Undi Hoffler; Kristen Hobbie; Ralph Wilson; Re Bai; Akef Rahman; David Malarkey; Greg Travlos; Burhan I Ghanayem
Journal:  Endocrine       Date:  2009-08-11       Impact factor: 3.633

3.  Serum leptin levels and insulin resistance are associated with gallstone disease in overweight subjects.

Authors:  Nahum Méndez-Sánchez; Luisa-B Bermejo-Martínez; Yolanda Viñals; Norberto-C Chavez-Tapia; Irina Vander Graff; Guadalupe Ponciano-Rodríguez; Martha-H Ramos; Misael Uribe
Journal:  World J Gastroenterol       Date:  2005-10-21       Impact factor: 5.742

Review 4.  Impaired cardiac function in leptin-deficient mice.

Authors:  Jun Ren; Heng Ma
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

5.  Hypothyroidism in rats decreases peripheral glucose utilisation, a defect partially corrected by central leptin infusion.

Authors:  P Cettour-Rose; C Theander-Carrillo; C Asensio; M Klein; T J Visser; A G Burger; C A Meier; F Rohner-Jeanrenaud
Journal:  Diabetologia       Date:  2005-03-09       Impact factor: 10.122

6.  Changes in insulin sensitivity during leptin replacement therapy in leptin-deficient patients.

Authors:  Gilberto Paz-Filho; Karin Esposito; Barry Hurwitz; Anil Sharma; Chuanhui Dong; Victor Andreev; Tuncay Delibasi; Halil Erol; Alejandro Ayala; Ma-Li Wong; Julio Licinio
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-14       Impact factor: 4.310

Review 7.  Obesity and lipodystrophy--where do the circles intersect?

Authors:  Farid F Chehab
Journal:  Endocrinology       Date:  2008-01-17       Impact factor: 4.736

8.  Evidence of impairment of normal inflammatory reaction by a high-fat diet.

Authors:  C Laflamme; G Bertheau-Mailhot; M S Giambelluca; N Cloutier; E Boilard; M Pouliot
Journal:  Genes Immun       Date:  2014-02-27       Impact factor: 2.676

9.  Leptin and Adiponectin: new players in the field of tumor cell and leukocyte migration.

Authors:  Kerstin Lang; Janina Ratke
Journal:  Cell Commun Signal       Date:  2009-12-23       Impact factor: 5.712

10.  Leptin and soluble leptin receptor levels in plasma and risk of type 2 diabetes in U.S. women: a prospective study.

Authors:  Qi Sun; Rob M van Dam; James B Meigs; Oscar H Franco; Christos S Mantzoros; Frank B Hu
Journal:  Diabetes       Date:  2009-12-03       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.